Summary

The global Biomaterials market is projected to reach USD 68.93 billion by 2030 from USD 48.36 billion in 2025, at CAGR of 7.3% from 2025 to 2030. The expansion of the Global Biomaterials market has been fueled by the advancements in healthcare facilities and systems, and the rising advancements in smart, biocompatible, and 3D-printed biomaterials.
In 2024, The metallic biomaterials held the highest share in the Global Biomaterials market by type.

https://mnmimg.marketsandmarkets.com/Images/biomaterials-img-overview.webp

The market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials. The highest share by type was of metallic biomaterials due to their wide application in orthopedic, dental, and cardiovascular fields. The mechanical properties make them the suitable for application in implants such as joint replacements, fracture fixation devices, dental implants, and stints. The commonly used biomaterials are titanium and its alloys, stainless steel, cobalt chromoly alloys, and more recently, biodegradable metal alloys like magnesium-based metal. These exhibit remarkable resistance to fatigue failure, corrosion, and remarkable compatibility. They were also found to be safe for long-term use in a physiological environment. However, constant progress in surface modification technologies such as surface modification through coating and surface treatment has greatly improved their osseointegration, friction, and resistance to infections. Moreover, rising surgical procedures, an ageing population, and an increase in musculoskeletal and cardiac disorders are expected to propel the demand for metallic biomaterials across the globe, consolidating their strong position in the global biomaterials.


“Joint replacement segment reported for the highest share of the orthopedic application segment in 2024.”

Within the application segment, the Global Biomaterials market is divided into Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Tissue engineering, neurological application Wound Healing, Urinary application, and Other Applications. In 2024, Joint replacement represents the leading segment in orthopedic applications in the global biomaterials. Due to an increasing number of people suffering from degenerative joint diseases like osteoarthritis and rheumatoid arthritis. factors like an aging population, and an increasing rate of obesity have also led to an increasing number of people undergoing knee, shoulder, or hip replacements. However, materials used in joint replacements, have improved strength, durability, or biocompatibility that makes these materials highly suitable for applications involving heavy loading. Advances in implant design, surface technology, or method of implantation also continue to increase patient survival with these implants. Furthermore, increasing utilization of minimal invasiveness in surgeries, increasing availability of orthopedic care in developing nations, or ever-improving implant technologies continue to drive this market.

APAC accounted for the fastest growing market share in the global Biomaterials market from 2025 to 2030.

The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period . This surge is driven by rapid healthcare infrastructure expansion in China, India, and Japan, alongside booming medical tourism and rising chronic disease burdens like orthopedics and cardiology. An aging population, government R&D investments, and adoption of 3D-printed implants and bioresorbable polymers fuel demand for advanced metallic, polymeric, and ceramic solutions in joint replacements, stents, and tissue engineering. Local manufacturing hubs and regulatory streamlining further accelerate market penetration, positioning APAC as a key innovation powerhouse.

The primary interviews conducted for this report can be categorized as follows:

? By Respondent: Supply Side-70% and Demand Side-30%
? By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
? By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5%
List of Key Companies Profiled in the Report:
Key players in the Global Biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).
Research Coverage:
This research report categorizes the Global Biomaterials market, By Type: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, By Application: Cardiovascular Orthopaedic, Dental, Plastic Surgery, Urinary, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/Central Nervous System, Other Applications. and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Biomaterials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the Global Biomaterials market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall Biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
? Analysis of key drivers (Rising advancements in smart, biocompatible, and 3D-printed biomaterials, Advancements in healthcare facilities and systems), restraints (High development and production costs associated with advanced biomaterials.), opportunities (Expanding applications in tissue engineering and regenerative medicine.) and Challenges (Concerns related to biocompatibility, safety, and adverse immune responses).
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the Global Biomaterials market
? Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
? Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Global Biomaterials market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the Global Biomaterials market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 57
1.1 STUDY OBJECTIVES 57
1.2 MARKET DEFINITION 57
1.2.1 INCLUSIONS & EXCLUSIONS 58
1.3 STUDY SCOPE 59
1.3.1 MARKET SEGMENTATION 59
1.3.2 REGIONAL SCOPE 60
1.3.3 YEARS CONSIDERED 60
1.3.4 CURRENCY CONSIDERED 60
1.4 RESEARCH LIMITATIONS 61
1.5 STAKEHOLDERS 61
1.6 SUMMARY OF CHANGES 61
2 EXECUTIVE SUMMARY 63
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 63
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS 64
2.3 DISRUPTIVE TRENDS SHAPING BIOMATERIALS MARKET 65
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 66
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 67
3 PREMIUM INSIGHTS 68
3.1 BIOMATERIALS MARKET OVERVIEW 68
3.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY, 2025 69
3.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT 70
4 MARKET OVERVIEW 71
4.1 INTRODUCTION 71
4.2 MARKET DYNAMICS 71
4.2.1 DRIVERS 72
4.2.1.1 Rising advancements in smart, biocompatible, and 3D printed biomaterials 72
4.2.1.2 Advancements in healthcare systems, physical infrastructure, and reimbursement frameworks 73
4.2.1.3 Growing demand for biomaterials in wound healing and plastic surgery 73
4.2.1.4 Increasing use of biomaterials in multiple therapeutic areas 74
4.2.2 RESTRAINTS 74
4.2.2.1 High development and production cost of advanced biomaterials 74
?
4.2.3 OPPORTUNITIES 75
4.2.3.1 Expanding applications in tissue engineering and regenerative medicine 75
4.2.3.2 Development of novel biomaterials 75
4.2.4 CHALLENGES 76
4.2.4.1 Concerns related to biocompatibility, safety, and adverse immune responses 76
4.3 UNMET NEEDS & WHITE SPACES 76
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 77
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 77
5 INDUSTRY TRENDS 79
5.1 PORTER’S FIVE FORCES ANALYSIS 79
5.1.1 THREAT OF NEW ENTRANTS 80
5.1.2 THREAT OF SUBSTITUTES 80
5.1.3 BARGAINING POWER OF BUYERS 80
5.1.4 BARGAINING POWER OF SUPPLIERS 80
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.2 MACROECONOMIC OUTLOOK 81
5.2.1 GDP TRENDS AND FORECAST 81
5.2.2 TRENDS IN GLOBAL BIOMATERIALS MARKET 82
5.3 VALUE CHAIN ANALYSIS 82
5.4 ECOSYSTEM ANALYSIS 84
5.4.1 ROLE IN ECOSYSTEM 85
5.5 PRICING ANALYSIS 86
5.5.1 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 86
5.5.2 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 87
5.6 TRADE ANALYSIS 88
5.6.1 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021?2025 88
5.6.2 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021?2025 89
5.6.3 IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021?2025 90
5.6.4 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021?2025 91
5.6.5 IMPORT DATA FOR HS CODE 284329 (SILVER), 2021?2025 92
5.6.6 EXPORT DATA FOR HS CODE 284329 (SILVER), 2021?2025 93
5.6.7 IMPORT VOLUME FOR HS 284329 (SILVER), 2021?2025 94
5.6.8 EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021?2025 95
5.6.9 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021?2025 96
5.6.10 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021?2025 97
5.6.11 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021?2025 98
5.6.12 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021?2025 99
5.6.13 IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021?2025 100
5.6.14 EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021?2025 101
5.6.15 IMPORT VOLUME FOR HS 3910 (SILICONE), 2021?2025 102
5.6.16 EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021?2025 103
5.7 KEY CONFERENCES & EVENTS, 2026?2027 104
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 104
5.9 INVESTMENT & FUNDING SCENARIO 105
5.10 CASE STUDY ANALYSIS 106
5.10.1 SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING 106
5.10.2 STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS 107
5.10.3 ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP 107
5.11 IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET 108
5.11.1 INTRODUCTION 108
5.11.2 KEY TARIFF RATES 108
5.11.3 PRICE IMPACT ANALYSIS 109
5.11.4 IMPACT ON COUNTRY/REGION 109
5.11.4.1 North America 109
5.11.4.2 Europe 110
5.11.4.3 Asia Pacific 110
5.11.5 IMPACT ON END-USE INDUSTRIES 111
5.11.5.1 Medical device manufacturers 111
5.11.5.2 Pharmaceutical & biotechnology companies 111
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 112
6.1 TECHNOLOGY ANALYSIS 112
6.1.1 KEY TECHNOLOGIES 112
6.1.1.1 Precision technologies 112
6.1.1.2 Biomimetics 112
6.1.2 ADJACENT TECHNOLOGIES 113
6.1.2.1 3D bioprinting 113
6.1.2.2 Electrospinning 113
6.2 TECHNOLOGY/PRODUCT ROADMAP 114
6.3 PATENT ANALYSIS 115
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015?2025 115
6.3.2 LIST OF PATENTS 116
6.4 FUTURE APPLICATIONS 116
6.5 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET 116
6.5.1 TOP USE CASES AND MARKET POTENTIAL 117
6.5.2 CASE STUDIES OF AI IMPLEMENTATION 118
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 118
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 118
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 120
7.1 REGIONAL REGULATIONS & COMPLIANCE 120
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120
7.1.2 REGULATORY FRAMEWORK 123
7.1.3 INDUSTRY STANDARDS 125
7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 125
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 126
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 127
8.1 DECISION-MAKING PROCESS 127
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 127
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 127
8.2.2 KEY BUYING CRITERIA, BY END USER 128
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 129
8.4 UNMET NEEDS FROM KEY END-USE INDUSTRIES 130
8.5 MARKET PROFITABILITY 130
9 BIOMATERIALS MARKET, BY TYPE 131
9.1 INTRODUCTION 132
9.2 METALLIC BIOMATERIALS 133
9.2.1 STAINLESS STEEL 134
9.2.1.1 Favorable mechanical properties, corrosion resistance, and cost-effectiveness to drive usage 134
9.2.2 TITANIUM & TITANIUM ALLOYS 135
9.2.2.1 Rising number of joint replacement procedures to aid market growth 135
9.2.3 COBALT-CHROME ALLOYS 136
9.2.3.1 Low cost and excellent corrosion resistance to augment market growth 136
9.2.4 SILVER 137
9.2.4.1 Toxic properties and low aesthetic to limit use of silver in biomaterial-based products 137
9.2.5 GOLD 138
9.2.5.1 Expanding applications of gold nanoparticles to drive demand for gold biomaterials 138
9.2.6 MAGNESIUM 139
9.2.6.1 Biodegradable characteristics of magnesium to aid segment growth 139
9.2.7 OTHER METALLIC BIOMATERIALS 139
9.3 POLYMERIC BIOMATERIALS 140
9.3.1 POLYMETHYLMETHACRYLATE (PMMA) 142
9.3.1.1 Long-standing clinical record demonstrating safety and biocompatibility to spur market growth 142
9.3.2 POLYETHYLENE 143
9.3.2.1 Wear and tear resistance of polyethylene to popularize usage in hip and knee joint replacements 143
9.3.3 POLYESTER 144
9.3.3.1 Biodegradable nature and biocompatibility to boost use in various medical applications 144
9.3.4 POLYVINYLCHLORIDE 145
9.3.4.1 Heavy chlorine content of polyvinylchloride to hamper market growth 145
9.3.5 SILICONE RUBBER 146
9.3.5.1 Non-reactive, stable, and resistant in extreme environments and temperatures to drive adoption of silicone rubber 146
9.3.6 NYLON 146
9.3.6.1 Low weight, corrosion resistance, and wide applications to propel market demand 146
9.3.7 POLYETHERETHERKETONE 147
9.3.7.1 Polyetheretherketone to gain popularity as viable alternative to metals 147
9.3.8 OTHER POLYMERIC BIOMATERIALS 148
9.4 CERAMIC BIOMATERIALS 148
9.4.1 CALCIUM PHOSPHATE 149
9.4.1.1 Close structural and chemical resemblance to natural bone and teeth to drive adoption in biomedical applications 149
9.4.2 ZIRCONIA 150
9.4.2.1 Bio-inertness and low wear rate of zirconia to boost market adoption 150
9.4.3 ALUMINUM OXIDE 151
9.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive market 151
9.4.4 CALCIUM SULFATE 152
9.4.4.1 Better biocompatibility and bioresorbability to augment market adoption 152
9.4.5 CARBON 152
9.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment to drive market growth 152
9.4.6 GLASS 153
9.4.6.1 Rising number of orthopedic and dental procedures to fuel demand for glass biomaterials 153
9.5 NATURAL BIOMATERIALS 154
9.5.1 HYALURONIC ACID 156
9.5.1.1 Rising incidences of osteoarthritis to drive hyaluronic acid biomaterials market 156
9.5.2 COLLAGEN 157
9.5.2.1 High tensile strength to be useful in plastic and cosmetic surgeries, cardiology, ophthalmology, and drug delivery 157
9.5.3 FIBRIN 157
9.5.3.1 Fibrin biomaterials to be useful in clinical practice for controlling bleeding and accelerating wound repair 157
9.5.4 CELLULOSE 158
9.5.4.1 Cellulose to be useful in wound healing, skin regeneration, and ophthalmology 158
9.5.5 CHITIN 159
9.5.5.1 Chitin to accelerate skin regeneration and possess high biocompatibility 159
9.5.6 ALGINATES 160
9.5.6.1 Use in wound healing, tissue engineering & regenerative medicine, and drug delivery to drive adoption 160
9.5.7 GELATIN 160
9.5.7.1 Low cost and comparable biocompatibility of gelatin to fuel market adoption 160
9.5.8 CHITOSAN 161
9.5.8.1 Non-toxicity of Chitosan to increase adoption in biomedical research 161
9.5.9 SILK 162
9.5.9.1 Flexibility and adhesive abilities to drive usage in wound healing applications 162
9.5.10 OTHER NATURAL BIOMATERIALS 163
10 BIOMATERIALS MARKET, BY APPLICATION 165
10.1 INTRODUCTION 166
10.2 ORTHOPEDIC 166
10.2.1 JOINT REPLACEMENT 167
10.2.1.1 Knee replacement 168
10.2.1.1.1 Rising count of knee replacement procedures globally to drive market growth 168
10.2.1.2 Hip replacement 169
10.2.1.2.1 Hip & knee joint replacements to be most commonly performed procedures 169
10.2.1.3 Shoulder replacement 170
10.2.1.3.1 Increasing shoulder surgeries to drive production of implants 170
10.2.1.4 Other joint replacement applications 171
10.2.2 BIORESORBABLE TISSUE FIXATION 171
10.2.2.1 Suture anchors 172
10.2.2.1.1 Growing awareness about suture anchor devices to propel market growth 172
10.2.2.2 Interference screws 173
10.2.2.2.1 Growing ACL reconstruction procedures to contribute to market growth 173
10.2.2.3 Meniscal repair tacks 174
10.2.2.3.1 Rising sports injuries to fuel growth in meniscal repair tacks market 174
10.2.2.4 Meshes 175
10.2.2.4.1 Wear resistance and proper shaping of bioresorbable implants to increase demand for bioresorbable meshes 175
10.2.3 SPINE SURGERIES 175
10.2.3.1 Spinal fusion 176
10.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth 176
10.2.3.2 Minimally invasive fusion 177
10.2.3.2.1 Lesser post-surgery pain and faster recovery to drive demand for minimally invasive fusion procedures 177
10.2.3.3 Motion preservation & dynamic stabilization 178
10.2.3.3.1 Pedicle-based rod systems 179
10.2.3.3.1.1 Rising geriatric population to result in market growth 179
10.2.3.3.2 Interspinous spacers 180
10.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to market growth 180
10.2.3.3.3 Artificial discs 180
10.2.3.3.3.1 High biocompatibility to increase usage in artificial discs 180
10.2.4 FRACTURE FIXATION DEVICES 181
10.2.4.1 Bone plates 182
10.2.4.1.1 High biocompatibility of biomaterials to be an integral component of bone plates 182
10.2.4.2 Screws 183
10.2.4.2.1 Metallic biomaterial screws to be extensively used in orthopedic procedures 183
10.2.4.3 Pins 183
10.2.4.3.1 Nonreactive nature of metallic biomaterial pins to favor usage in fracture fixation 183
10.2.4.4 Rods 184
10.2.4.4.1 High rigidity, easy mobility, and cost efficiency to make rods preferred for fracture fixation procedures 184
10.2.4.5 Wires 184
10.2.4.5.1 Wires made up of metallic biomaterials to help treat fractures of small bones 184
10.2.5 ORTHOBIOLOGICS 185
10.2.5.1 Rising cases of osteoarthritis to drive growth in viscosupplementation market 185
10.3 CARDIOVASCULAR 186
10.3.1 CATHETERS 187
10.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market 187
10.3.2 STENTS 188
10.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents 188
10.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 189
10.3.3.1 Growing geriatric population and rising prevalence of chronic diseases to drive market 189
10.3.4 PACEMAKERS 190
10.3.4.1 High prevalence of bradycardia to aid demand for pacemakers 190
10.3.5 SENSORS 190
10.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors 190
10.3.6 HEART VALVES 191
10.3.6.1 Growing geriatric population to increase demand for prosthetic valves 191
10.3.7 VASCULAR GRAFTS 192
10.3.7.1 Focus on research on use of biomaterials in vascular grafts to open opportunities for market growth 192
10.3.8 GUIDEWIRES 193
10.3.8.1 Guidewires to be used for guiding catheters and placing stents inside the heart 193
10.3.9 OTHER CARDIOVASCULAR APPLICATIONS 194
10.4 OPHTHALMOLOGY 194
10.4.1 CONTACT LENSES 195
10.4.1.1 Growing cases of refractive errors and preference for contact lenses over spectacles to drive market growth 195
10.4.2 INTRAOCULAR LENSES 196
10.4.2.1 Increasing prevalence of cataracts to boost number of cataract surgeries performed 196
10.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 197
10.4.3.1 Increasing funding and research activities for developing bionic eyes to propel segment growth 197
10.4.4 SYNTHETIC CORNEAS 198
10.4.4.1 Increasing number of corneal blindness cases globally to boost demand for synthetic collagen biomaterials 198
10.4.5 OTHER OPHTHALMOLOGY APPLICATIONS 198
10.5 DENTAL 199
10.5.1 DENTAL IMPLANTS 200
10.5.1.1 Rising awareness about dental health and increasing dental procedures to augment market growth 200
10.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 201
10.5.2.1 Growing demand for dental implants during cosmetic dentistry to drive market 201
10.5.3 DENTAL MEMBRANES 202
10.5.3.1 Dental membranes in oral and periodontal surgery to prevent unwanted infections in oral cavity 202
10.5.4 TISSUE REGENERATION MATERIALS 202
10.5.4.1 Increasing prevalence of periodontal disease to augment market growth 202
10.6 PLASTIC SURGERY 203
10.6.1 SOFT TISSUE FILLERS 204
10.6.1.1 Long-lasting capacity and fewer allergic reactions to drive demand for soft-tissue fillers 204
?
10.6.2 CRANIOFACIAL SURGERY 205
10.6.2.1 Increasing incidence of trauma cases and head & neck cancer to augment market growth 205
10.6.3 FACIAL WRINKLE TREATMENT 206
10.6.3.1 Increase in demand for non-surgical cosmetic treatments to propel market growth 206
10.6.4 BIOENGINEERED SKINS 207
10.6.4.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries 207
10.6.5 PERIPHERAL NERVE REPAIR 208
10.6.5.1 Increasing incidence of trauma cases to rise in peripheral nerve injuries 208
10.6.6 ACELLULAR DERMAL MATRICES 208
10.6.6.1 Ability to provide scaffold for tissue regeneration and reduce risk of immune rejection and adverse reactions to drive segment 208
10.7 WOUND HEALING 209
10.7.1 WOUND CLOSURE DEVICES 210
10.7.1.1 Sutures 211
10.7.1.1.1 Sutures to be used as advanced biologically active components for better drug delivery 211
10.7.1.2 Staples 212
10.7.1.2.1 Ease of placement and ability to shorten closure to augment segment growth 212
10.7.2 SURGICAL HEMOSTATS 213
10.7.2.1 Surgical hemostats to control bleeding and reduce frequent blood transfusions during surgical procedures 213
10.7.3 INTERNAL TISSUE SEALANTS 213
10.7.3.1 Increasing number of surgeries to drive use of internal tissue sealants 213
10.7.4 ADHESION BARRIERS 214
10.7.4.1 Focus on inflammatory healing process to drive adoption of adhesion barriers in surgical procedures 214
10.7.5 HERNIA MESHES 214
10.7.5.1 Polymeric biomaterial-based meshes to be used in hernia repair 214
10.7.6 SKIN SUBSTITUTES 215
10.7.6.1 Focus on prompting tissue regeneration and replacing damaged skin with functional tissue to aid market growth 215
10.8 TISSUE ENGINEERING 216
10.8.1 SCAFFOLDS FOR BIOMATERIALS 217
10.8.1.1 Rise in organ transplantation procedures to drive market 217
10.8.2 NANOMATERIALS FOR BIOSENSING 218
10.8.2.1 Rising research in nanotechnology to augment market growth 218
10.8.3 TAILORING OF INORGANIC NANOPARTICLES 218
10.8.3.1 Growing demand for nanotechnological medical products to drive market 218
?
10.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 219
10.9.1 SHUNTING SYSTEMS 220
10.9.1.1 Rising cases of hydrocephalus to boost market growth 220
10.9.2 CORTICAL NEURAL PROSTHETICS 221
10.9.2.1 Increased use of polymer-coated CNPs to treat paralyzed patients 221
10.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR 222
10.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds 222
10.9.4 NEURAL STEM CELL ENCAPSULATION 222
10.9.4.1 Lack of substitutes for neurotrauma treatment to boost market growth 222
10.10 URINARY 223
10.10.1 URINARY CATHETERS 224
10.10.1.1 Rise in implant-related cases of biofilm-associated infections to hinder market growth 224
10.10.2 URETHRAL STENTS 225
10.10.3 OTHER URINARY APPLICATIONS 225
10.11 OTHER APPLICATIONS 226
10.11.1 DRUG DELIVERY SYSTEMS 227
10.11.2 GASTROINTESTINAL APPLICATIONS 228
10.11.3 BARIATRIC SURGERY 229
11 BIOMATERIALS MARKET, BY END USER 230
11.1 INTRODUCTION 231
11.2 MEDICAL DEVICE MANUFACTURERS 231
11.2.1 DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET 231
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 232
11.3.1 INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION 232
11.4 OTHER END USERS 233
12 BIOMATERIALS MARKET, BY REGION 235
12.1 INTRODUCTION 236
12.2 NORTH AMERICA 236
12.2.1 US 247
12.2.1.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market 247
12.2.2 CANADA 257
12.2.2.1 Growing incidence of cardiovascular diseases to propel market growth 257
12.3 EUROPE 266
12.3.1 GERMANY 276
12.3.1.1 Rising focus on clinical research and increasing number of patent approvals to aid market growth 276
12.3.2 UK 286
12.3.2.1 Increasing research activities and rising number of cardiovascular procedures to support market growth 286
12.3.3 FRANCE 295
12.3.3.1 Increased healthcare expenditure and structured regulatory framework to augment market growth 295
12.3.4 ITALY 304
12.3.4.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth 304
12.3.5 SPAIN 314
12.3.5.1 Increased focus on research for biomaterial development to propel market growth 314
12.3.6 REST OF EUROPE 323
12.4 ASIA PACIFIC 333
12.4.1 CHINA 344
12.4.1.1 Lucrative medical devices industry and large geriatric population to drive market 344
12.4.2 JAPAN 353
12.4.2.1 Growing medical devices industry and rising focus on medical research to support market growth 353
12.4.3 INDIA 363
12.4.3.1 Large population base and high focus on medical tourism to aid market growth 363
12.4.4 SOUTH KOREA 373
12.4.4.1 High demand for healthcare services and advanced treatments to spur market growth 373
12.4.5 AUSTRALIA 382
12.4.5.1 Strategic public and sector-wide investments with clinical trial system reform to underpin biomedical research growth 382
12.4.6 REST OF ASIA PACIFIC 392
12.5 LATIN AMERICA 402
12.5.1 BRAZIL 412
12.5.1.1 Gradual increase in pharmaceutical R&D to fuel market growth 412
12.5.2 MEXICO 421
12.5.2.1 Rising number of cosmetic procedures to boost adoption of biomaterials 421
12.5.3 ARGENTINA 430
12.5.3.1 Increased incidence of cardiovascular diseases and favorable government healthcare system to aid market growth 430
12.5.4 REST OF LATIN AMERICA 440
12.6 MIDDLE EAST 450
12.6.1 GCC COUNTRIES 460
12.6.1.1 Kingdom of Saudi Arabia 470
12.6.1.1.1 Increasing prevalence of cardiovascular diseases to drive market 470
?
12.6.1.2 UAE 479
12.6.1.2.1 Strategic partnerships and regulatory alignment to drive global biomaterials market growth 479
12.6.1.3 Rest of GCC countries 488
12.6.2 REST OF MIDDLE EAST 498
12.7 AFRICA 508
12.7.1 EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH 508
13 COMPETITIVE LANDSCAPE 518
13.1 INTRODUCTION 518
13.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 518
13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET 518
13.3 REVENUE ANALYSIS, 2023?2025 519
13.4 MARKET SHARE ANALYSIS, 2025 520
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 522
13.5.1 STARS 522
13.5.2 EMERGING LEADERS 522
13.5.3 PERVASIVE PLAYERS 523
13.5.4 PARTICIPANTS 523
13.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025 524
13.5.5.1 Company footprint 524
13.5.5.2 Region footprint 525
13.5.5.3 Type footprint 526
13.5.5.4 Application footprint 527
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 528
13.6.1 PROGRESSIVE COMPANIES 528
13.6.2 RESPONSIVE COMPANIES 528
13.6.3 DYNAMIC COMPANIES 528
13.6.4 STARTING BLOCKS 528
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 530
13.6.5.1 List of key startups/SMEs 530
13.6.5.2 Competitive benchmarking of key startups/SMEs 531
13.7 COMPANY VALUATION & FINANCIAL METRICS 531
13.7.1 FINANCIAL METRICS 531
13.7.2 COMPANY VALUATION 532
13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 533
13.9 COMPETITIVE SCENARIO 533
13.9.1 PRODUCT LAUNCHES 534
13.9.2 DEALS 534
13.9.3 EXPANSIONS 535
?
14 COMPANY PROFILES 536
14.1 KEY PLAYERS 536
14.1.1 BASF SE 536
14.1.1.1 Business overview 536
14.1.1.2 Products/Services/Solutions offered 537
14.1.1.3 Recent developments 538
14.1.1.3.1 Deals 538
14.1.1.3.2 Other developments 539
14.1.1.4 MnM view 539
14.1.1.4.1 Right to win 539
14.1.1.4.2 Strategic choices 539
14.1.1.4.3 Weaknesses & competitive threats 539
14.1.2 COVESTRO AG 540
14.1.2.1 Business overview 540
14.1.2.2 Products/Services/Solutions offered 541
14.1.2.3 Recent developments 543
14.1.2.3.1 Product launches 543
14.1.2.3.2 Deals 543
14.1.2.3.3 Expansions 543
14.1.2.3.4 Other developments 544
14.1.2.4 MnM view 544
14.1.2.4.1 Right to win 544
14.1.2.4.2 Strategic choices 544
14.1.2.4.3 Weaknesses & competitive threats 544
14.1.3 CELANESE CORPORATION 545
14.1.3.1 Business overview 545
14.1.3.2 Products/Services/Solutions offered 546
14.1.3.3 Recent developments 548
14.1.3.3.1 Deals 548
14.1.3.4 MnM view 548
14.1.3.4.1 Right to win 548
14.1.3.4.2 Strategic choices 548
14.1.3.4.3 Weaknesses & competitive threats 549
14.1.4 CARPENTER TECHNOLOGY CORPORATION 550
14.1.4.1 Business overview 550
14.1.4.2 Products/Services/Solutions offered 551
14.1.4.2.1 Other developments 552
14.1.4.3 MnM view 553
14.1.4.3.1 Right to win 553
14.1.4.3.2 Strategic choices 553
14.1.4.3.3 Weaknesses & competitive threats 553
?
14.1.5 EVONIK INDUSTRIES AG 554
14.1.5.1 Business overview 554
14.1.5.2 Products/Services/Solutions offered 555
14.1.5.3 Recent developments 558
14.1.5.3.1 Product launches 558
14.1.5.3.2 Deals 558
14.1.5.4 MnM view 559
14.1.5.4.1 Right to win 559
14.1.5.4.2 Strategic choices 559
14.1.5.4.3 Weaknesses & competitive threats 559
14.1.6 DSM 560
14.1.6.1 Business overview 560
14.1.6.2 Products/Services/Solutions offered 561
14.1.6.3 Recent developments 563
14.1.6.3.1 Deals 563
14.1.6.3.2 Expansions 564
14.1.7 CORBION NV 565
14.1.7.1 Business overview 565
14.1.7.2 Products/Services/Solutions offered 566
14.1.7.3 Recent developments 568
14.1.7.3.1 Expansions 568
14.1.8 VICTREX PLC 569
14.1.8.1 Business overview 569
14.1.8.2 Products/Services/Solutions offered 570
14.1.8.3 Recent developments 571
14.1.8.3.1 Product launches 571
14.1.8.3.2 Expansions 571
14.1.9 MITSUBISHI CHEMICAL CORPORATION 572
14.1.9.1 Business overview 572
14.1.9.2 Products/Services/Solutions offered 573
14.1.10 COORSTEK INC. 574
14.1.10.1 Business overview 574
14.1.10.2 Products/Services/Solutions offered 574
14.1.11 BERKELEY ADVANCED BIOMATERIALS 575
14.1.11.1 Business overview 575
14.1.11.2 Products/Services/Solutions offered 575
14.1.12 CAM BIOCERAMICS B.V. 577
14.1.12.1 Business overview 577
14.1.12.2 Products/Services/Solutions offered 577
14.1.12.3 Recent developments 578
14.1.12.3.1 Deals 578
?
14.1.13 ZEUS COMPANY INC. 579
14.1.13.1 Business overview 579
14.1.13.2 Products/Services/Solutions offered 579
14.1.13.3 Recent developments 581
14.1.13.3.1 Product launches 581
14.1.13.3.2 Expansions 581
14.1.14 AMETEK INC. 582
14.1.14.1 Business overview 582
14.1.14.2 Products/Services/Solutions offered 583
14.1.14.3 Recent developments 583
14.1.14.3.1 Deals 583
14.1.14.3.2 Expansions 584
14.1.15 GELITA AG 585
14.1.15.1 Business overview 585
14.1.15.2 Products/Services/Solutions offered 585
14.1.15.3 Recent developments 587
14.1.15.3.1 Product launches 587
14.2 OTHER PLAYERS 588
14.2.1 COLLAGEN SOLUTIONS (US) LLC) 588
14.2.2 BIOCOMPOSITES 589
14.2.3 NOBLE BIOMATERIALS, INC. 590
14.2.4 REGENITY 590
14.2.5 KURARAY CO., LTD. 591
14.2.6 SOLESIS 593
14.2.7 INSTITUT STRAUMANN AG 594
14.2.8 FOSTER CORPORATION 595
14.2.9 CDI PRODUCTS 596
14.2.10 REVBIO, INC. 597
15 RESEARCH METHODOLOGY 598
15.1 RESEARCH DATA 598
15.1.1 SECONDARY DATA 599
15.1.1.1 Key objectives of secondary research 599
15.1.2 PRIMARY DATA 599
15.1.2.1 Breakdown of primaries 600
15.1.2.2 Key objectives of primary research 600
15.2 MARKET ESTIMATION METHODOLOGY 601
15.3 MARKET SIZE ESTIMATION 601
15.3.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) 601
15.3.2 MNM REPOSITORY ANALYSIS 603
15.3.3 PRIMARY INTERVIEWS 603
15.3.4 INSIGHTS OF PRIMARY EXPERTS 603
15.3.5 TOP-DOWN APPROACH 604
15.4 MARKET GROWTH RATE PROJECTIONS 605
15.5 DATA TRIANGULATION 607
15.6 STUDY ASSUMPTIONS 608
15.7 RESEARCH LIMITATIONS 608
15.8 RISK ANALYSIS 609
16 APPENDIX 610
16.1 DISCUSSION GUIDE 610
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 615
16.3 CUSTOMIZATION OPTIONS 617
16.4 RELATED REPORTS 617
16.5 AUTHOR DETAILS 618

ページTOPに戻る

List of Tables/Graphs

TABLE 1 BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS 58
TABLE 2 IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET 72
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON BIOMATERIALS MARKET 80
TABLE 4 ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM 85
TABLE 5 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD) 86
TABLE 6 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD) 87
TABLE 7 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY,
2021?2025 (USD THOUSAND) 88
TABLE 8 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY,
2021?2025 (USD THOUSAND) 89
TABLE 9 IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY,
2021?2025 (TONS) 90
TABLE 10 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY,
2021?2025 (TONS) 91
TABLE 11 IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY,
2021?2025 (USD THOUSAND) 92
TABLE 12 EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY,
2021?2025 (USD THOUSAND) 93
TABLE 13 IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY,
2021?2025 (TONS) 94
TABLE 14 EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY,
2021?2025 (TONS) 95
TABLE 15 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY,
2021?2025 (USD THOUSAND) 96
TABLE 16 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY,
2021?2025 (USD THOUSAND) 97
TABLE 17 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY,
2021?2025 (TONS) 98
TABLE 18 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY,
2021?2025 (TONS) 99
TABLE 19 IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY,
2021?2025 (USD THOUSAND) 100
TABLE 20 EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY,
2021?2025 (USD THOUSAND) 101
TABLE 21 IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY,
2021?2025 (TONS) 102
TABLE 22 EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021?2025 (TONS) 103
TABLE 23 KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET,
JANUARY 2026?DECEMBER 2027 104
TABLE 24 CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING 106
TABLE 25 CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS 107
TABLE 26 CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP 107
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 108
TABLE 28 INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025 116
TABLE 29 CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET 118
TABLE 30 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET 119
TABLE 31 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 32 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 33 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 34 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 35 COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS 124
TABLE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 128
TABLE 37 KEY BUYING CRITERIA, BY END USER 128
TABLE 38 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 132
TABLE 39 BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 133
TABLE 40 METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 133
TABLE 41 METALLIC BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 134
TABLE 42 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 135
TABLE 43 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 136
TABLE 44 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 137
TABLE 45 SILVER BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 138
TABLE 46 GOLD BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 138
TABLE 47 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 139
TABLE 48 OTHER METALLIC BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 140
TABLE 49 APPLICATIONS OF SYNTHETIC POLYMERS 141
TABLE 50 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 141
TABLE 51 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 142
TABLE 52 POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 143
TABLE 53 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 144
TABLE 54 POLYESTER BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 145
TABLE 55 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 145
TABLE 56 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 146
TABLE 57 NYLON BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 147
TABLE 58 POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 148
TABLE 59 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 148
TABLE 60 CERAMIC BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 149
TABLE 61 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 149
TABLE 62 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 150
TABLE 63 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 151
TABLE 64 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 151
TABLE 65 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 152
TABLE 66 CARBON BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 153
TABLE 67 GLASS BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 154
TABLE 68 APPLICATIONS OF NATURAL BIOMATERIALS 154
TABLE 69 NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 155
TABLE 70 NATURAL BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 156
TABLE 71 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 156
TABLE 72 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 157
TABLE 73 FIBRIN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 158
TABLE 74 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 159
TABLE 75 CHITIN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 159
TABLE 76 ALGINATES BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 160
TABLE 77 GELATIN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 161
TABLE 78 CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 162
TABLE 79 SILK BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 163
TABLE 80 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 164
TABLE 81 BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 166
TABLE 82 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 167
TABLE 83 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 167
TABLE 84 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 168
TABLE 85 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 168
TABLE 86 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 169
TABLE 87 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 170
TABLE 88 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 170
TABLE 89 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 171
TABLE 90 BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 172
TABLE 91 BIORESORBABLE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 172
TABLE 92 SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 173
TABLE 93 INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 174
TABLE 94 MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 174
TABLE 95 MESH BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 175
TABLE 96 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2024?2031 (USD MILLION) 176
TABLE 97 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2024?2031 (USD MILLION) 176
TABLE 98 SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 177
TABLE 99 MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 178
TABLE 100 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024?2031 (USD MILLION) 178
TABLE 101 MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET,
BY REGION, 2024?2031 (USD MILLION) 179
TABLE 102 PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 179
TABLE 103 INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 180
TABLE 104 ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 181
TABLE 105 BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE,
2024?2031 (USD MILLION) 181
TABLE 106 FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 182
TABLE 107 BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 182
TABLE 108 SCREW BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 183
TABLE 109 PIN BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 184
TABLE 110 ROD BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 184
TABLE 111 WIRE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 185
TABLE 112 ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 186
TABLE 113 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 187
TABLE 114 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 187
TABLE 115 CATHETER BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 188
TABLE 116 STENT BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 189
TABLE 117 IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 189
TABLE 118 PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 190
TABLE 119 SENSOR BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 191
TABLE 120 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 191
TABLE 121 HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 192
TABLE 122 VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 193
TABLE 123 GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 193
TABLE 124 OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 194
TABLE 125 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 126 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 195
TABLE 127 CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 196
TABLE 128 INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 197
TABLE 129 FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET,
BY REGION, 2024?2031 (USD MILLION) 197
TABLE 130 SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 198
TABLE 131 OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 199
TABLE 132 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 199
TABLE 133 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 200
TABLE 134 DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 201
TABLE 135 DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 201
TABLE 136 DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 202
TABLE 137 TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 203
TABLE 138 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 203
TABLE 139 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 204
TABLE 140 SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 205
TABLE 141 CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 206
TABLE 142 FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 207
TABLE 143 BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 207
TABLE 144 PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 208
TABLE 145 ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 209
TABLE 146 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 209
TABLE 147 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 210
TABLE 148 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 210
TABLE 149 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 211
TABLE 150 SUTURE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 212
TABLE 151 STAPLE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 212
TABLE 152 SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 213
TABLE 153 INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 214
TABLE 154 ADHESION BARRIER BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 214
TABLE 155 HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 215
TABLE 156 SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 216
TABLE 157 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 216
TABLE 158 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 217
TABLE 159 SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 217
TABLE 160 NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 218
TABLE 161 TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 219
TABLE 162 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 219
TABLE 163 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024?2031 (USD MILLION) 220
TABLE 164 SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 221
TABLE 165 CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 221
TABLE 166 HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 222
TABLE 167 NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 223
TABLE 168 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 223
TABLE 169 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 224
TABLE 170 URINARY CATHETER BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 225
TABLE 171 URETHRAL STENT BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 225
TABLE 172 OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 226
TABLE 173 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 226
TABLE 174 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 227
TABLE 175 DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 228
TABLE 176 GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 228
TABLE 177 BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION,
2024?2031 (USD MILLION) 229
TABLE 178 BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 231
TABLE 179 BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024?2031(USD MILLION) 232
TABLE 180 BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 233
TABLE 181 BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION,
2024?2031 (USD MILLION) 234
TABLE 182 BIOMATERIALS MARKET, BY REGION, 2024?2031 (USD MILLION) 236
TABLE 183 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 237
TABLE 184 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 238
TABLE 185 NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 238
TABLE 186 NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 238
TABLE 187 NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 188 NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 189 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 240
TABLE 190 NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 240
TABLE 191 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 241
TABLE 192 NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 241
TABLE 193 NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 241
TABLE 194 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 195 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 196 NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 197 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 199 NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 244
TABLE 200 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 244
TABLE 201 NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 245
TABLE 202 NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 245
TABLE 203 NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 245
TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 205 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 206 NORTH AMERICA: BIOMATERIALS MARKET, BY END USER,
2024?2031 (USD MILLION) 246
TABLE 207 US: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 247
TABLE 208 US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 248
TABLE 209 US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 248
TABLE 210 US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 211 US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 212 US: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 250
TABLE 213 US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 250
TABLE 214 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 215 US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 216 US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 217 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE,
2024?2031 (USD MILLION) 252
TABLE 218 US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 252
TABLE 219 US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 252
TABLE 220 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 253
TABLE 221 US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 253
TABLE 222 US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 254
TABLE 223 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 254
TABLE 224 US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 255
TABLE 225 US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 226 US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 227 US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 256
TABLE 228 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 256
TABLE 229 US: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 256
TABLE 230 CANADA: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 231 CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 232 CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 258
TABLE 233 CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 258
TABLE 234 CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 259
TABLE 235 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 259
TABLE 236 CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 260
TABLE 237 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 260
TABLE 238 CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 261
TABLE 239 CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 261
TABLE 240 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 261
TABLE 241 CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 262
TABLE 242 CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 262
TABLE 243 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 262
TABLE 244 CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 263
TABLE 245 CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 263
TABLE 246 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 264
TABLE 247 CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 264
TABLE 248 CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 264
TABLE 249 CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 250 CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 251 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 252 CANADA: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 266
TABLE 253 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 266
TABLE 254 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 267
TABLE 255 EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 267
TABLE 256 EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 267
TABLE 257 EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 268
TABLE 258 EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 268
TABLE 259 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 269
TABLE 260 EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 269
TABLE 261 EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 270
TABLE 262 EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 270
TABLE 263 EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 270
TABLE 264 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 271
TABLE 265 EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 271
TABLE 266 EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 271
TABLE 267 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 272
TABLE 268 EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 272
TABLE 269 EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 273
TABLE 270 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 273
TABLE 271 EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 274
TABLE 272 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 274
TABLE 273 EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 274
TABLE 274 EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 275
TABLE 275 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 275
TABLE 276 EUROPE: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 275
TABLE 277 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 276
TABLE 278 GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 277
TABLE 279 GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 277
TABLE 280 GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 278
TABLE 281 GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 278
TABLE 282 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 279
TABLE 283 GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 279
TABLE 284 GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 280
TABLE 285 GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 286 GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 287 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 281
TABLE 288 GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 281
TABLE 289 GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 281
TABLE 290 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 282
TABLE 291 GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 282
TABLE 292 GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 283
TABLE 293 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 283
TABLE 294 GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 295 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 284
TABLE 296 GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 284
TABLE 297 GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 298 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 299 GERMANY: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 285
TABLE 300 UK: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 286
TABLE 301 UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 286
TABLE 302 UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 287
TABLE 303 UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 287
TABLE 304 UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 288
TABLE 305 UK: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 288
TABLE 306 UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 289
TABLE 307 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 289
TABLE 308 UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 290
TABLE 309 UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 290
TABLE 310 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE,
2024?2031 (USD MILLION) 290
TABLE 311 UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 291
TABLE 312 UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 291
TABLE 313 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 291
TABLE 314 UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 292
TABLE 315 UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 292
TABLE 316 UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 293
TABLE 317 UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 293
TABLE 318 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 293
TABLE 319 UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 294
TABLE 320 UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 294
TABLE 321 UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 294
TABLE 322 UK: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 295TABLE 323 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 295
TABLE 324 FRANCE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 296
TABLE 325 FRANCE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 296
TABLE 326 FRANCE: POLYMERIC BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 297
TABLE 327 FRANCE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 297
TABLE 328 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 298
TABLE 329 FRANCE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 298
TABLE 330 FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 299
TABLE 331 FRANCE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 299
TABLE 332 FRANCE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 299
TABLE 333 FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 300
TABLE 334 FRANCE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 300
TABLE 335 FRANCE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 300
TABLE 336 FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 301
TABLE 337 FRANCE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 301
TABLE 338 FRANCE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 302
TABLE 339 FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 302
TABLE 340 FRANCE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 303
TABLE 341 FRANCE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS,
BY TYPE, 2024?2031 (USD MILLION) 303
TABLE 342 FRANCE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 303
TABLE 343 FRANCE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 304
TABLE 344 FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 304
TABLE 345 FRANCE: BIOMATERIALS MARKET, BY END USER, 2024?2031 (USD MILLION) 304
TABLE 346 ITALY: BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 305
TABLE 347 ITALY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 305
TABLE 348 ITALY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 306
TABLE 349 ITALY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 306
TABLE 350 ITALY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024?2031 (USD MILLION) 307
TABLE 351 ITALY: BIOMATERIALS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 307
TABLE 352 ITALY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024?2031 (USD MILLION) 308
TABLE 353 ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 308
TABLE 354 ITALY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 309
TABLE 355 ITALY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE,
2024?2031 (USD MILLION) 309
TABLE 356 ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024?2031 (USD MILLION) 309
TABLE 357 ITALY: BIORE